Argo Biopharma
PrivateLast Round
Series A
Extension
Nov 1, 2023
Total Funding Raised
$110M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Argo Biopharma is a biotechnology company that develops next-generation siRNA therapeutics for various diseases, including cardiovascular, viral, metabolic, and rare conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Argo Biopharma Comparables
Compare Argo Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sirius Therapeutics, Inc. | 91% | |
| Rona Therapeutics | 87% | |
| Sanegene Bio | 86% | |
Argo Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 1, 2023 | ||||
| Series A | Mar 23, 2022 | ||||
| Angel | May 1, 2021 |
Key People
Founding team and executive leadership
Argo Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Loyal Valley Capital | Series A |
| Huagai Capital | Series A Extension |
| GSR United Capital | Series A |
| CS Capital | Series A Extension |
| Tao Capital Partners | Series A |
| CPE | Series A |
| Apricot Capital | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 3, 2026
Open roles increased to 397, 1203% of headcount.
- Jul 20, 2026
Open roles increased to 367, 1112% of headcount.
Argo Biopharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Argo Biopharma's valuation, stock price, and market status.